Počet záznamov: 1
sarkoidóza pľúcna
SYS d017565 LBL 00000nz--a2200000o--4500 005 20250606213424.9 008 930303|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a C08.381.483.725 065 $a C15.604.515.827.725 065 $a C20.543.418.575.725 066 $a 01 $c 03 150 $a sarkoidóza pľúcna $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo 450 $w v $a Pulmonary Sarcoidosis $2 eng 450 $w v $a sarkoidóza pulmonálna $2 slo 665 $a 94 $2 eng 665 $a Lung Diseases (1966-1993) $2 eng 665 $a Sarcoidosis (1966-1993) $2 eng 680 9-
$i Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431) $2 eng 750 -2
$a Sarcoidosis, Pulmonary $2 eng 980 $x M
Počet záznamov: 1